RecruitingNot ApplicableNCT06074666

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3


Sponsor

Roswell Park Cancer Institute

Enrollment

100 participants

Start Date

Nov 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.


Eligibility

Min Age: 3 YearsMax Age: 9 Years

Inclusion Criteria6

  • Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  • Parent has primary medication responsibility.
  • Pediatric patient aged 3-9 years
  • Child on therapy that includes home-based oral anti-cancer medication taken at home, such as 6-MP.
  • Parent has verbal English or Spanish fluency.
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria6

  • Parent of a child who is not diagnosed nor being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  • Parent does not have primary medication responsibility.
  • Pediatric patient aged 3-9 years
  • Pediatric patient is not on therapy that includes oral anti-cancer medication (e.g., 6-MP).
  • Parent does not have verbal English or Spanish fluency.
  • Parent is unwilling or unable to follow protocol requirements

Interventions

BEHAVIORALCareMeds Intervention

3 parenting sessions will be offered during weeks 2 through 4 of the study period.

BEHAVIORALUsual Care Group

3 parenting sessions will be offered during weeks 13 through 15 of the study period.


Locations(1)

Roswell Park Comprehensive Cancer Center

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06074666


Related Trials